5
Skybiotech Healthcare
KAPILCOTEXLTD NSE
Skybiotech Healthcare
TextilesNSE: KAPILCOTEXLTD BSE: 512036 Textile Processing
Key Fundamentals
MicrocapTextile ProcessingTextilesMarket Cap
₹23.10 Cr
Volatility
Low Risk
P/E Ratio
-13.8
EBITDA
₹-1.47 Cr
Return on Equity
-22.48%
Debt to Equity
1.05
Book Value
₹41.75
EPS
₹14.76
52W High
₹220
52W Low
₹116.45
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
4- Stock is trading at 2.89 times its book value
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
- Debtor days have increased from 39.5 to 57.1 days.
Growth Rate
Revenue Growth
-4.05%
Net Income Growth
-30.42%
Cash Flow Change
-230% lower than
5Y
ROE
—
ROCE
—
EBITDA Margin (Avg.)
-21.18%
Quarterly Results
| Particulars | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 1.6 | 2.52 | 1.02 | 2.39 | 1.92 | 0.96 | 1.83 | 0.49 |
| Expenses | 0.05 | 0.04 | 1.58 | 2.83 | 2.11 | 2.31 | 2.15 | 1.41 | 2.71 | 1.02 |
| Operating Profit | -0.05 | -0.04 | 0.02 | -0.31 | -1.09 | 0.08 | -0.23 | -0.45 | -0.88 | -0.53 |
| OPM % | — | — | 1.25% | -12.3% | -106.86% | 3.35% | -11.98% | -46.88% | -48.09% | -108.16% |
| Other Income | 1.37 | 0.35 | 0.04 | 0.15 | -0.18 | 0.03 | 0.04 | 0.08 | 0.15 | 0.06 |
| Interest | 0 | 0 | 0.13 | 0.11 | -0.23 | 0.01 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0.13 | 0.14 | 0.15 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 |
| PBT | 1.32 | 0.31 | -0.2 | -0.41 | -1.19 | -0.02 | -0.31 | -0.49 | -0.85 | -0.58 |
| Tax % | 18.94% | 19.35% | 30% | -4.88% | -8.4% | 0% | 0% | 0% | -64.71% | 0% |
| Net Profit | 1.07 | 0.25 | -0.25 | -0.39 | -1.08 | -0.02 | -0.31 | -0.48 | -0.3 | -0.57 |
| EPS in Rs | 5.59 | 1.31 | -1.31 | -2.04 | -5.64 | -0.1 | -1.62 | -2.51 | -1.57 | -2.98 |
Profit & Loss
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 0 | 6.96 | 7.1 | 5.2 |
| Expenses | 0.12 | 9.21 | 8.58 | 7.29 |
| Operating Profit | -0.12 | -2.25 | -1.48 | -2.09 |
| OPM % | — | -32.33% | -20.85% | -40.19% |
| Other Income | 2 | 0.38 | 0.31 | 0.33 |
| Interest | 0 | 0.01 | 0.02 | 0 |
| Depreciation | 0 | 0.54 | 0.48 | 0.47 |
| PBT | 1.88 | -2.42 | -1.67 | -2.23 |
| Tax % | 18.09% | -2.07% | -32.93% | — |
| Net Profit | 1.54 | -2.37 | -1.12 | -1.66 |
| EPS in Rs | 8.04 | -12.38 | -5.85 | -8.68 |
| Div. Payout % | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | — | 1.92 | 1.92 |
| Reserves | — | 7.07 | 6.08 |
| Borrowings | — | 7.2 | 8.42 |
| Other Liabilities | — | 3.91 | 3.02 |
| Total Liabilities | — | 20.1 | 19.44 |
| Fixed Assets | — | 12.03 | 11.55 |
| CWIP | — | 0 | 0 |
| Investments | — | 2.46 | 2.24 |
| Other Assets | — | 5.61 | 5.65 |
| Total Assets | — | 20.1 | 19.44 |
Cash Flow
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Operating | — | -1.04 | -1.52 |
| Investing | — | -9.63 | 0.02 |
| Financing | — | 1.24 | 1.17 |
| Net Cash Flow | — | -9.43 | -0.33 |
| Free Cash Flow | — | -1.37 | -1.52 |
| CFO/OP | — | 46 | 103 |
Ratios
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Debtor Days | — | 22.03 | 57.06 |
| Inventory Days | — | — | 74.68 |
| Days Payable | — | — | 79.35 |
| Cash Conversion Cycle | — | 22.03 | 52.4 |
| Working Capital Days | — | -18.88 | -1.03 |
| ROCE % | — | — | -9.32% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Skybiotech Healthcare insights
57 extracted metrics + investor summaries across FY00–FY26.
Documents
1
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Confirmed non-applicability of SEBI Large Corporate norms as of March 31, 2026. 30 Apr - Confirmed non-applicability of SEBI Large Corporate norms as of March 31, 2026.
2
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
30 Apr - Confirmed non-applicability of SEBI Large Corporate norms as of March 31, 2026. 30 Apr - Confirmed non-applicability of SEBI Large Corporate norms as of March 31, 2026.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Regulation 74(5) certificate filed for quarter ended 31 March 2026; no physical shares received for demat. 9 Apr - Regulation 74(5) certificate filed for quarter ended 31 March 2026; no physical shares received for demat.
5
Board Meeting Outcome for Outcome Of Board Meeting To Considered And Approved Un-Audited Financials For The Quarter Ended On 31St December, 2025
14 Feb - Board approved standalone and consolidated unaudited results for quarter ended 31-Dec-2025; consolidated Q3 loss Rs48.47 lakh. 14 Feb - Board approved standalone and consolidated unaudited results for quarter ended 31-Dec-2025; consolidated Q3 loss Rs48.47 lakh.
Frequently Asked Questions about Skybiotech Healthcare
What does Skybiotech Healthcare Limited do?
Incorporated in 1983, Skybiotech Healthcare Ltd is in the business of Textile and Pharmaceuticals[1]
Where is Skybiotech Healthcare Limited (512036) listed?
Skybiotech Healthcare Limited trades as KAPILCOTEXLTD on the NSE and under code 512036 on the BSE.
Which sector does Skybiotech Healthcare Limited belong to?
Skybiotech Healthcare Limited is classified under the Textiles sector, in the Textile Processing industry.
What is the market capitalisation of Skybiotech Healthcare Limited?
Skybiotech Healthcare Limited has a market capitalisation of ₹23.1 Cr, which places it in the Small Cap band.
What is the PE ratio of Skybiotech Healthcare Limited?
Skybiotech Healthcare Limited trades at a PE ratio of -13.80, on earnings per share of ₹14.76, against a book value of ₹41.75 per share.
What is the 52-week high and low of Skybiotech Healthcare Limited?
Over the last 52 weeks Skybiotech Healthcare Limited has traded between ₹116.45 and ₹220.
What is the Return on Equity (ROE) of Skybiotech Healthcare Limited?
Skybiotech Healthcare Limited reported a return on equity of -22.48%. Its debt-to-equity ratio is 1.05.
Company Information
Incorporated in 1983, Skybiotech Healthcare Ltd is in the business of Textile and Pharmaceuticals[1]
Website kapilcotex.co.in
Face Value ₹ 10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/512036.md for Skybiotech Healthcare Limited: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.